NCT03879070

Brief Summary

The proposed clinical investigation plan is a randomized controlled pivotal study with 2 parallel groups, has a total duration of two years. For the study, 30 pediatric patients suffering from acquired brain injury will be recruited at the Scientific institute Eugenio Medea. The primary aim of this study is to assess the clinical benefit of using an ankle mobilization device for the rehabilitation of pediatric patients with acquired brain injuries, on its clinical performance and its risks, and on its safety. The efficacy of the treatment will be evaluated in terms of ankle range of motion (primary outcome). The effects of the treatment on musculoskeletal plasticity will be studied using an isokinetic machine and functional magnetic resonance imaging will provide information on variations of reactivity in the motor cortical network. Ease of use, safety and usability of the device will also be evaluated.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 13, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 18, 2019

Completed
11 months until next milestone

Study Start

First participant enrolled

February 1, 2020

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2021

Completed
Last Updated

March 2, 2023

Status Verified

March 1, 2023

Enrollment Period

11 months

First QC Date

March 13, 2019

Last Update Submit

March 1, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Passive range of motion of ankle dorsi-plantarflexion

    Measured with goniometer

    Change from baseline after 4 weeks of treatment

Secondary Outcomes (4)

  • Ankle joint stiffness

    Change from baseline after 4 weeks of treatment

  • Medical Research Council (MRC) Scale for Muscle Strength

    Change from baseline after 4 weeks of treatment

  • Cerebral activation

    Change from baseline after 4 weeks of treatment

  • Time-Domain Near-Infrared Spectroscopy

    Change from baseline after 4 weeks of treatment

Study Arms (2)

Intervention group

EXPERIMENTAL
Device: Ankle active and passive mobilization using an Ankle mobilization device

Control group

NO INTERVENTION

Interventions

The treatment consists in 20 rehabilitation sessions, 5 times/week for 4 weeks. The device is capable of generating ankle dorsi/plantarflexion movements using two activation modes: passive and assistive. In the passive mode the device generates a movement pattern which the patient follows passively without exerting any force on the device. During the assistive mode, the device follows the active movement of the patient. During the intervention, these two modes will be alternated.

Intervention group

Eligibility Criteria

Age6 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Tetraplegic and hemiplegic acquired brain injury patients, within first month of injury.
  • Spastic syndrome (ankle joint Modified Ashworth Scale \> 1).

You may not qualify if:

  • Pace maker or other contraindication to Magnetic Resonance Imaging scans.
  • Other serious comorbidity.
  • Behaviour and psychiatric disorders.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IRCCS E. Medea

Bosisio Parini, Lecco, 23842, Italy

Location

MeSH Terms

Conditions

Brain Injuries

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and Injuries

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 13, 2019

First Posted

March 18, 2019

Study Start

February 1, 2020

Primary Completion

January 1, 2021

Study Completion

February 1, 2021

Last Updated

March 2, 2023

Record last verified: 2023-03

Locations